ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質(癌免疫療法用)

ACROBiosystems社 プロダクトリスト:Recombinant Protein

サプライヤー
AcroBioSystems
カタログNo.
CDA-H82F6
製品名称
Biotinylated Human LILRB3 / CD85a / ILT5 Protein, Fc Tag, Avi Tag (Avitag)
タンパク質名
Fc gamma RIIIB / CD16b (NA1)
Species
Human
HOST
HEK293
25ug: 74,000円
お問い合わせ
200ug: 290,000円
お問い合わせ

Overview

Synonyms Fc gamma RIIIB / CD16b (NA1),FCGR3B,CD16B,FCG3B,FCGR3,FCG3,IGFR3
Characteristics This protein carries a human IgG1 Fc tag at the C-terminus, followed by a Avi tag (Avitag). The protein has a calculated MW of 74.5 kDa. As a result of glycosylation, the protein migrates as 80-105 kDa under reducing (R) condition, and 150 kDa under non-
Endotoxin Level Less than 1.0 EU per μg by the LAL method.
Purity >95% as determined by SDS-PAGE.
Description Leukocyte immunoglobulin-like receptor subfamily B member 3 is also known as LILRB3,ILT-5 or CD85a. LILRB3 plays an role as receptor for class I MHC antigens, which activated upon coligation of LILRB3 and immune receptors, such as FCGR2B and the B-cell receptor. LILRB3 and LILRA6 represent a pair of inhibitory/activating receptors with identical extracellular domains and unknown ligands. LILRB3 can mediate inhibitory signaling via immunoreceptor tyrosine-based inhibition motifs in its cytoplasmic tail whereas LILRA6 can signal through association with an activating adaptor molecule, FcRγ.
Reference (1) Bashirova AA., et al., 2014, Immunogenetics.66(1):1-8.
(2) Huang J., et al., 2010, J Virol. 84(18):9463-9471.
(3) Pfistershammer K., et al., 2009, Blood. 114(11):2323-2332.
URL https://www.acrobiosystems.com/P2362-Biotinylated-Human-LILRB3--CD85a--ILT5-Protein-Fc-Tag-Avi-Tag-%28Avitag%E2%84%A2%29.html

お問い合わせリスト(-)

お問い合わせフォーム